Baumal Caroline 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 21, 2026
Research Summary
AI-generated summary of this filing
Apellis (APLS) CMO Caroline Baumal Sells 1,882 Shares
What Happened
- Caroline Baumal, Chief Medical Officer of Apellis Pharmaceuticals (APLS), sold 1,882 shares in a sale reported for January 20, 2026. The shares were disposed at $19.79 each for a total of approximately $37,250. This was a sale (not a purchase) and was done to satisfy tax withholding related to Restricted Stock Units (RSUs) that vested on January 16, 2026.
Key Details
- Transaction date and price: 2026-01-20 at $19.79 per share.
- Shares sold: 1,882; proceeds ≈ $37,250.
- Transaction type: Sale (open market or private sale as reported).
- Footnote: Sale executed to cover tax withholding on RSUs released Jan 16, 2026 (per filing note F1).
- Shares owned after transaction: Not specified in the provided filing details.
- Filing timeliness: No late filing indicated in the provided data.
Context
- Sales to cover tax withholding on RSU vesting are routine and do not necessarily indicate a change in insider confidence. They are administrative transactions to satisfy tax obligations rather than discretionary market-timing trades.
Insider Transaction Report
Form 4
Baumal Caroline
Chief Medical Officer
Transactions
- Sale
Common Stock
[F1]2026-01-20$19.79/sh−1,882$37,250→ 89,324 total
Footnotes (1)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 16, 2026.
Signature
/s/ David Watson, attorney-in-fact for Caroline Baumal|2026-01-21